» Articles » PMID: 16021276

Follow-up of Children and Adolescents with Short Stature: the Importance of the Growth Rate

Overview
Journal Sao Paulo Med J
Specialty General Medicine
Date 2005 Jul 16
PMID 16021276
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Context And Objective: Short stature is defined as a height of more than two standard deviations below the average for a given age and sex in a reference population. The objective was to describe follow-up conducted among short-stature children and adolescents.

Design And Setting: Descriptive study, at the Growth outpatient clinic, Department of Pediatrics, Universidade Federal de São Paulo.

Methods: The study included 152 patients aged 2 to 15 years who had height for age of less than P5, on the National Center for Health Statistics curve. The children underwent nutritional evaluation, and several variables relating to height and growth rate were calculated to establish etiological diagnosis. Bone age was evaluated by X-ray.

Results: The majority (63.2%) were male. In 77.8%, the stature observed was within the family pattern. Among the 99 patients followed up for more than 6 months, 17.2% presented inadequate growth rates. The preponderant etiological diagnosis for short stature was familial/constitutional in 58.6% of the cases; 27 patients (34.2%) with adequate growth rate presented bone age alterations. Even with inadequate growth rates, 75% of such patients had a normal result from growth hormone stimulation testing. Close to 90% of patients with a diagnosis of short stature of familial/constitutional origin and intrauterine growth retardation presented adequate growth rate. The genetic etiology was significantly characteristic of patients with inadequate growth rate.

Conclusion: Growth rate assessment must form part of the investigation and follow-up of short-stature cases. However, its utilization and validity should form part of an overall view of each patient.

Citing Articles

A Proposal for the Interpretation of Serum IGF-I Concentration as Part of Laboratory Screening in Children with Growth Failure.

Wit J, Bidlingmaier M, de Bruin C, Oostdijk W J Clin Res Pediatr Endocrinol. 2019; 12(2):130-139.

PMID: 31842524 PMC: 7291410. DOI: 10.4274/jcrpe.galenos.2019.2019.0176.


Stature-weight growth delays: Clinical and etiological aspects.

Salhi H, Lahlou A, Dante M, El Ouahabi H, Boujraf S, Ajdi F J Family Med Prim Care. 2019; 7(5):963-966.

PMID: 30598941 PMC: 6259559. DOI: 10.4103/jfmpc.jfmpc_207_16.

References
1.
Must A, Dallal G, Dietz W . Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr. 1991; 53(4):839-46. DOI: 10.1093/ajcn/53.4.839. View

2.
Argente J, Abusrewil S, Bona G, Chiarelli F, Kelnar C, Skordis N . Isolated growth hormone deficiency in children and adolescents. J Pediatr Endocrinol Metab. 2001; 14 Suppl 2:1003-8. DOI: 10.1515/jpem-2001-s213. View

3.
Alexander G, Himes J, Kaufman R, Mor J, Kogan M . A United States national reference for fetal growth. Obstet Gynecol. 1996; 87(2):163-8. DOI: 10.1016/0029-7844(95)00386-X. View

4.
Voss L, Mulligan J, Betts P, Wilkin T . Poor growth in school entrants as an index of organic disease: the Wessex growth study. BMJ. 1992; 305(6866):1400-2. PMC: 1883947. DOI: 10.1136/bmj.305.6866.1400. View

5.
Tanner J, Goldstein H, Whitehouse R . Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child. 1970; 45(244):755-62. PMC: 1647404. DOI: 10.1136/adc.45.244.755. View